MOTS-c
Mitochondrial signal.
- Lyophilised powderFormat
- 2–4 weeksVial coverage
- 2 mL BAC waterReconstitution
What it is, in plain language
MOTS-c is a 16-amino-acid peptide encoded within mitochondrial DNA. Unlike most peptides, it originates from the mitochondria themselves, acting as a metabolic regulator that communicates with the rest of the cell.
Research has positioned MOTS-c as a key signal in exercise, metabolic flexibility, and the aging process. It is consistently described in the literature as a "training-paired" compound — the effects are amplified when administration overlaps with a structured training block.
MOTS-c is encoded inside the mitochondrion itself — a metabolic signal sent from the energy organelle out to the rest of the cell.
How it works
MOTS-c is reported to activate the AMPK pathway, a central regulator of cellular energy. Research findings include enhanced glucose uptake, improved insulin sensitivity, and increased fat utilisation in animal models.
What the literature shows
Animal studies have reported sustained improvements in glucose homeostasis and exercise capacity.
Effects appear to be amplified by training during the dosing window — MOTS-c is consistently described as a "training-paired" compound in the literature, and the on-phase is usually scheduled to overlap with a structured training block.
Protocol reference
Common research-grade reference figures. Not medical advice — every protocol must be reviewed against the latest published literature and your study design.
Standard 4–8 weeks on, 2–4 weeks off. Extended 12-week protocols seen in dedicated metabolic research. Annual ceiling: 2–3 cycles. Best paired with a structured training block during the on-phase. After 8+ weeks, washout helps re-assess whether benefits persist or require re-dosing.
2 mL BAC → 10 mg/mL. Draw 0.5 mL = 5 mg; 1.0 mL = 10 mg.
Lyophilised vial: room temperature short-term, refrigerator long-term. Reconstituted: refrigerate; use within 28 days when reconstituted with bacteriostatic water.
Common questions
Why is MOTS-c described as "exercise-paired"?
Detailed answer coming soon. In the meantime, see the mechanism and protocol sections above, or email hello@aeonco.com.au.
How does it differ from other metabolic compounds?
Detailed answer coming soon. In the meantime, see the mechanism and protocol sections above, or email hello@aeonco.com.au.
Can MOTS-c run alongside the regenerative line?
Detailed answer coming soon. In the meantime, see the mechanism and protocol sections above, or email hello@aeonco.com.au.
What is the AMPK pathway in plain terms?
Detailed answer coming soon. In the meantime, see the mechanism and protocol sections above, or email hello@aeonco.com.au.
Can MOTS-c be stacked with Retatrutide or Semaglutide?
Detailed answer coming soon. In the meantime, see the mechanism and protocol sections above, or email hello@aeonco.com.au.
Stack partners
Retatrutide 10mg
Investigational triple-receptor agonist (GLP-1 / GIP / Glucagon)
View product →Semaglutide 20mg
GLP-1 receptor agonist · weight & metabolic research
View product →NAD+ 500mg
Nicotinamide adenine dinucleotide · cellular energy research
View product →